// App-Quantinova.ai

PB1653 : MODIFIED DELPHI CONSENSUS ON THE RELEVANCE OF MINIMAL RESIDUAL TESTING IN MULTIPLE MYELOMA IN THE CLINICAL PRACTICE

Researchers

Presenter

  • Karthik Ramasamy

Principal Investigators

  • Herv Avet-Loiseau

  • Cecilie Hveding Blimark

  • Michel Delforge

  • Francesca Gay

  • Salomon Manier

  • Joaqun Martinez-Lopez

  • Maria Victoria Mateos

  • Mohamad Mohty

  • Niels W.C.J. van de Donk

  • Katja Weisel

Medical Centers

  • University Hospital of Salamanca

  • Salamanca Biomedical Research Institute,Salamanca,Spain

  • VU University Medical Center, Amsterdam, Netherlands

  • University Institute of Cancer Toulouse &amp

  • Oxford University, Oxford, United Kingdom

  • Hospital Saint-Antoine &amp

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • Oxford University Hospitals NHS Foundation Trust &amp

  • University of Turin, Turin, Italy

  • Univ of Lille, Lille, France

  • 12 de Octubre Universitary Hospital, Madrid, Spain

  • Sorbonne Universites, Paris, France

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University Hospital of Tours, Tours, France

  • Sahlgrenska University Hospital, Gothenburg, Sweden

Locations

  • Spain

  • Netherlands

  • France

  • United Kingdom

  • Belgium

  • Italy

  • Germany

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved